The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Targeted drugs – scattered goals (sponsored by a grant from Novartis Oncology)
Affiliation
National Center for Tumor Diseases (NCT), Heidelberg
Country
Germany
1. Current Status, Position
Dirk Jäger is Director Medical Oncology, University Medical Center Heidelberg.
2. Education
- Training internal medicine, hematology, oncology;
- 1998 – 2000: Research fellowship New York;
- 2005: Director Medical Oncology, Heidelberg.
3. Research Area
His research area is Tumor Immunology.
Conflict of interest: None.